跳至主要内容
临床试验/DRKS00013764
DRKS00013764招募中未知

Transcranial Direct Current Stimulation (tDCS) As Treatment for Major Depression - A Prospective Multicenter Double Blind Randomized Placebo Controlled Trial (DepressionDC) - DepressionDC

udwig-Maximilians-Universität München0 个研究点目标入组 152 人开始时间: 2018年4月13日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
152

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Men and women 18-65 years of age.
  • - Primary DSM-5 diagnosis of Major Depression as assessed by the Structured Clinical Interview for DSM-5 Axis I Disorders, Research Version (SCID-5-RV) with a single or recurrent episode with the additional requirements of a current episode with a duration of =4 weeks.
  • - Current depressive episode is less than 5 years duration (the definition of an episode is demarcated by a period of =2 months in which the patient did not meet full criteria for the DSM-5 definition of major depressive episode).
  • - Total HDRS-21 =15 at the screening visit.
  • - The patient did not respond to at least one antidepressant treatment, i.e., a minimum of 1 and a maximum of 4 antidepressant drug trials, of adequate dose and duration (defined as a minimum level of 2 on the ATHF) in the current episode.
  • - Patient is taking a SSRI of adequate dose and =4 weeks (defined as a minimum level of 2 on the ATHF) in the current episode.
  • - Capable and willing to provide informed consent.
  • - Negative pregnancy test and willingness to use contraceptive measures during study treatment for women with childbearing potential (i.e <. 2 years post-menopausal)

排除标准

  • - Investigators, site personnel directly affiliated with this study, and their immediate families (immediate family is defined as a spouse, parent, child or sibling, whether by birth or legal adoption).
  • - Acute risk for suicide (MADRS, item 10 score of >4 or as assessed by the C-SSRS, agree to item 4 and/or to item 5).
  • - High degree of therapy resistance defined as >4 sufficient treatment attempts in the current episode (each attempt with an ATHF score of >3).
  • - Treatment with electroconvulsive therapy in the present episode.
  • - Treatment with deep brain stimulation or vagus nerve stimulation and/or any other intracranial implants (clips, cochlear implants).
  • - Any other relevant psychiatric axis-I- and/or axis-II-disorder.
  • - Any relevant instable medical condition.
  • - History of treatment with tDCS for any disorder.
  • - Pregnancy.

研究者

发起方
udwig-Maximilians-Universität München

相似试验